BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 21, 2014
View Archived Issues
Researchers identify potential antiobesity drug target, describe potent inhibitor
Read More
BMS discovers novel isonicotinamides as selective and potent GSK-3 inhibitors
Read More
New O-GlcNAcase inhibitors patented by Alectos and Merck & Co
Read More
Lonza and BioWa sign cell-line technology licensing agreement with arGEN-X
Read More
IntelliCell BioSciences collaborates with the GAIN
Read More
BioAtla completes engineering of Telephus' MAb TPH-101
Read More
Novogen and CanTx advance experimental drug Trx-1
Read More
VaxInnate initiates phase I study of seasonal influenza vaccine VAX-2012Q
Read More
TapImmune signs option agreement for peptide epitopes targeting folate receptor alpha
Read More
Phase III trial of GSK's MAGE-A3 immunotherapeutic in NSCLC misses first co-primary endpoints
Read More
VolitionRx reports data from pilot study of NuQ
Read More
NeoGenomics launches two next-generation cancer sequencing tests
Read More
Horizon Pharma to acquire Vidara Therapeutics
Read More
SYL-933, a potent and selective S1P1 receptor agonist
Read More
U.S. and German researchers present new BACE1 inhibitors
Read More
Paliperidone palmitate 3-month formulation shows positive efficacy in schizophrenia study
Read More
Tetraphase Pharmaceuticals provides update on antibiotic candidate eravacycline
Read More
Chinese researchers patent novel DOT1L inhibitors
Read More
Pfizer's rLP-2086 receives FDA breakthrough therapy designation
Read More
Ryanodex NDA granted priority review by FDA
Read More
Mallinckrodt completes acquisition of Cadence Pharmaceuticals
Read More
Montana State University discloses new vaccines for brucellosis
Read More
Virax offers to acquire Pathway Oncology
Read More
Pfizer seeks additional indication approval in Japan for Solu-Medrol
Read More
IMP-3 as an independent prognostic biomarker of recurrence in endometrial adenocarcinoma
Read More
FDA approves Neuraceq for PET imaging of beta-amyloid neuritic plaque density
Read More
AVEO Oncology regains full rights to AV-203
Read More